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Neighbourhood socio-economic position,
late presentation and outcomes in people
living with HIV in Switzerland
Aysel Guelera, Franziska Schoeni-Affoltera,b, Andre´ Mosera,c,
Barbara Bertischa,d, Heiner C. Buchere,f, Alexandra Calmyg,
Matthias Cavassinih, Bruno Ledergerberi, Gilles Wandelera,j,
Matthias Eggera,k, for the Swiss HIV Cohort Study,
Swiss National Cohort
Objectives: Inequalities and inequities in health are an important public health con-
cern. In Switzerland, mortality in the general population varies according to the socio-
economic position (SEP) of neighbourhoods. We examined the influence of neighbour-
hood SEP on presentation and outcomes in HIV-positive individuals in the era of
combination antiretroviral therapy (cART).
Methods: The neighbourhood SEP of patients followed in the Swiss HIV Cohort Study
(SHCS) 2000–2013 was obtained on the basis of 2000 census data on the 50 nearest
households (education and occupation of household head, rent, mean number of
persons per room). We used Cox and logistic regression models to examine the
probability of late presentation, virologic response to cART, loss to follow-up and
death across quintiles of neighbourhood SEP.
Results: A total of 4489 SHCS participants were included. Presentation with advanced
disease [CD4þ cell count <200 cells/ml or AIDS] and with AIDS was less common in
neighbourhoods of higher SEP: the age and sex-adjusted odds ratio (OR) comparing the
highest with the lowest quintile of SEP was 0.71 [95% confidence interval (95% CI)
0.58–0.87] and 0.59 (95% CI 0.45–0.77), respectively. An undetectable viral load at 6
months of cART was more common in the highest than in the lowest quintile (OR 1.52;
95% CI 1.14–2.04). Loss to follow-up, mortality and causes of death were not
associated with neighbourhood SEP.
Conclusion: Late presentation was more common and virologic response to cART less
common in HIV-positive individuals living in neighbourhoods of lower SEP, but in
contrast to the general population, there was no clear trend for mortality.
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Introduction
Inequalities and inequities in health between countries,
regions and areas are an important public health concern
[1–3]. Such differences are not only explained by both
the characteristics and behaviours of the individuals living
in an area (compositional effects) but also by the social and
environmental characteristics of communities and neigh-
bourhoods (contextual factors) [4–6], including social
cohesion, health services and environmental factors. In
Switzerland, mortality varies substantially across neigh-
bourhoods of different socio-economic position (SEP)
[3]. Inequalities may be particularly pronounced in
patients with conditions that disproportionally affect the
socially vulnerable, such as infection with the HIV.
The main risk groups for HIV infection in Switzerland are
MSM, IDUs and people acquiring HIV-1 through
heterosexual intercourse [7]. Infections in migrants from
sub-Saharan Africa or Asia have become important in
recent years [8]. HIV-positive people often have significant
comorbidity but may face more barriers to access health
services [9], may be more likely to be unemployed [10] and
have fewer material and social resources but higher levels of
psychological distress [11], and less favourable health
behaviours than those free of HIV infection [12].
Late presentation with advanced immunodeficiency or
clinical AIDS is an important issue for care and prevention
of HIV infection. Timely diagnosis and successful
treatment with potent combination antiretroviral therapy
(cART) is both associated with improved prognosis and a
reduction of the risk of onward transmission of HIV
[13,14]. Loss to follow-up is also an issue: in the Swiss
HIV Cohort (SHCS), patients who were seen regularly at
a clinic were less likely to progress to AIDS [15].
We analysed data from the SHCS [16] to examine the
influence of neighbourhood and individual SEP on the
probability of late presentation, initiation and response to
cART, loss to follow-up (LTFU) and mortality.
Materials and methods
The Swiss HIV Cohort Study
The SHCS is a nationwide, prospective cohort study of
HIV-infected patients aged 16 years or older [16]. Socio-
demographic, clinical and laboratory data are recorded at
enrolment and in 6-monthly intervals. Clinical stage is
classified according to the clinical criteria of the Centers
for Disease Control and Prevention (CDC) [17]. Patients
who miss follow-up visits are traced and deaths in patients
lost to follow-up ascertained through municipalities and
mortality records. Written informed consent is obtained
from all participants. The present analysis was approved by
a Federal Expert Commission.
All treatment-naive patients who started cART between
2000 and 2013 at a University clinic or Cantonal hospital
and had a valid address were eligible. SHCS patients who
were seen in private practices and patients infected
through mother-to-child transmission were excluded.
The closing date of the database was April 2013.
Neighbourhood index of socio-economic
position
On the basis of Census 2000 data, the Swiss neighbour-
hood index of SEP is based on neighbourhoods of about 50
households [18]. Each household was spatially referenced
using the geographic coordinates of the building. Areas
centred on residences were then created. Boundaries
changed from one building to the next and were distorted
in the direction of roads with shops, amenities and public
transport. The SEPof neighbourhoods was determined on
the basis of rent per square metre, proportion of households
headed by a person with primary education or less,
proportion headed by a person in manual or unskilled
occupation and mean number of persons per room [18].
Geocoding
Patient addresses were coded in ArcGIS 10 software (Esri)
using the GeoPost database (Esri, Zurich, Switzerland),
which includes data on the exact geographical coordinates
of buildings. On the basis of the geocode, the Swiss SEP
neighbourhood index was allocated to each study parti-
cipant. The study number and neighbour SEP index, but
not geocodes or addresses, left clinics for further analyses.
Definition of outcomes and variables
We considered seven outcomes: late presentation;
presentation with advanced HIV disease; presentation
with AIDS-defining illness; time to start of cART;
virologic response to cART; LTFU; and mortality. Late
presentation was defined as a person with HIV first
presenting for care with a CD4þ cell count less than
350 cells/ml or with an AIDS-defining event [19].
Presentation with advanced HIV disease was defined
as presentation with a CD4þ cell count less than
200 cells/ml or with AIDS: patients presenting with
advanced disease are a subgroup of late presenters. First,
presentation for care was defined as the date of the first
positive HIV test or first CD4þ cell count recorded in the
database, whichever came first. Time to start of cART in
ART-naive patients was related to the time from
presentation to the start of therapy. Virologic response
to cARTwas defined as a viral load less than 50 copies/ml at
6 months among ART-naive patients followed for at least
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6 months. The viral load measurement closest to 6 months
of follow-up within a window of 3 months was used. A
patient was considered LTFU if the last visit was more than
14 months before the closing date of the database and the
patient was not known to have died. Only patients with
more than 14 months of potential follow-up, before closure
of the database, were included in the analysis of LTFU.
Causes of deaths were classified according to the Causes of
Death in HIV (CoDe) protocol (Version 2.3) [20], or
based on ICD-10 codes from the death certificate (Table
S1, http://links.lww.com/QAD/A603). We considered
patients as exposed to hepatitis C virus (HCV) if they had
positive anti-HCV or HCV-RNA tests and exposed to
hepatitis B virus (HBV) in the presence of positive anti-
HBc, HBs-antigen or HBV-DNA tests.
Statistical analysis
We used descriptive statistics to examine patient
characteristics across quintiles of neighbourhood SEP.
We used logistic regression (late presentation outcomes,
virologic response) and Cox proportional hazards models
(time to start of cART, LTFU and death from all causes).
In Cox models, time was measured from enrolment to the
time the outcome occurred or the last follow-up visit. In
patients starting cART at enrolment, we added 1 day of
follow-up. Schoenfeld’s test was used to assess the
proportional hazard assumption [21]. Models were
adjusted for age and sex. In additional analyses, variables
associated with individual-level SEP and variables that
may mediate effects of SEP were also included: education
(compulsory school, vocational training, higher edu-
cation, other/unknown), occupation (self-employed/
higher management, middle management, employee,
apprentice/trainee/student, other/unknown), smoking
(current smoker, other/unknown), source of income
(salaried work, welfare benefits, support from family or
partner, other/unknown), transmission group (hetero-
sexual, MSM, IDU, other/unknown), region of origin
(Switzerland, North-West Europe, Southern Europe,
sub-Saharan Africa, Latin America, Asia/ Eastern Europe,
other/unknown).
We imputed missing baseline CD4þ cell counts and viral
load values based on characteristics at baseline and
whether or not the patient died. Analyses were run on
each of 20 imputation datasets and combined with
Rubin’s rule [22]. We calculated mortality rates per
quintiles of the neighbourhood index of SEP both for the
SHCS and the general population. We used the Swiss
National Cohort, a census-based cohort of the entire
Swiss population [23].
Analyses were done in Stata (Stata Corp., College Station,
Texas, USA, version 12.0) and R (R Foundation for
Statistical Computing, Vienna, Austria, version 3.0.2).
Results are presented as odds ratios (ORs) and hazard
ratios, with 95% confidence intervals (CIs).
Results
A total of 6825 patients were enrolled into the SHCS
since 1 January 2000 of whom 2336 patients were
excluded, mainly because they were seen in associated
clinics and private practices wherein geocoding of
addresses was not possible. Excluded patients were more
likely to be MSM, to have higher education and to be in
salaried work than included patients (Table S2, http://
links.lww.com/QAD/A603). A total of 4489 patients
(69.7% male) were included in the analyses of mortality
with a median follow-up time of 5.4 years [interquartile
range (IQR) 2.8–8.7 years]. Fewer patients were
included in the analyses of other outcomes: 4218 for
late presentation, 4177 patients for presentation with
advanced disease, 4477 patients for LTFU, 3863 ART-
naive patients for time to starting cART and 2694 ART-
naive patients for virologic response at 6 months.
Supplemental Figure S1, http://links.lww.com/QAD/
A603 shows the selection of patients for the different
analyses. Only three CD4þ cell counts and 54 viral loads
at enrolment and 246 CD4þ cell counts and 268 viral
loads at the start of cART were missing and imputed.
Figure 1 shows a colour-coded map of the 1 298 079
neighbourhoods and their index of SEP. Neighbour-
hoods of higher SEP (in shades of green) are concentrated
in the urban centres, most notably in Zurich, Geneva,
Basel, Lausanne, Bern, Lugano and surroundings; and
along some of the lakes, for example, Lake Geneva and
Lake Zurich. Neighbourhoods of lower SEP (in shades of
red) dominate the regions north of the Alps, the area north
of the lakes of Neuchaˆtel and Bienne in the West of the
country and the valleys of the Alps. Clear differences in
neighbourhood SEP are also seen within cities, at the level
of streets (Figure S2, http://links.lww.com/QAD/A603).
There were substantial and statistically significant
differences in patient characteristics across quintiles of
neighbourhood SEP (Table 1). Fewer women lived in
neighbourhoods in the highest quintile of SEP than the
lowest quintile. The proportion of patients with a history
of IDU decreased with increasing SEP of neighbour-
hoods, whereas more MSM lived in high SEP
neighbourhoods. Patients living in neighbourhoods of
higher SEP had higher educational levels, were more
likely to work in managerial positions, less likely to smoke
and more likely to be Swiss citizens than those living in
neighbourhoods of lower SEP. Important differences
across neighbourhood SEP were also seen in clinical
characteristics (Table 2). For example, the percentage of
patients presenting with CDC clinical stage C, exposure
to HBV or HCV increased with decreasing SEP of
neighbourhoods, whereas the median CD4þ cell count at
start of cART decreased from 259 to 220 cells/ml.
At enrolment, there were 2571 (61.0%) late presenters,
1452 (34.8%) presenters with advanced HIV disease and
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691 (15.4%) patients with AIDS. A total of 3496 ART-
naive patients started cART. Median time from enrol-
ment to start of therapy was 11 days (IQR 1 day to 14.5
months). After starting cART, 2046 (76.0%) patients
suppressed viral replication by 6 months, 166 (3.7%) were
lost to follow-up and 246 (5.4%) patients died. Presentation
with advanced disease was less common in neighbour-
hoods of higher SEP: the age-adjusted and sex-adjusted
OR comparing the highest with the lowest quintile of the
neighbourhood SEP index was 0.71 (95% CI 0.58–0.87,
P¼ 0.003 from test of trend) (Table 3). For presentation
with AIDS, the corresponding OR was 0.59 (95% CI
0.45–0.77,P¼ 0.0002). Patients living in neighbourhoods
in the highest quintile of SEP were more likely to suppress
viral replication at 6 months after starting cART than those
living in neighbourhoods from the lowest quintile: OR
1.52 (95% CI 1.14–2.04, P¼ 0.05). There was little
evidence for a trend for time to start of cART, LTFU and
mortality (Table 3). Associations persisted but were
attenuated and no longer statistically significant when
additionally adjusting for individual-level variables trans-
mission group, region of origin, education, occupation,
smoking and source of income (supplemental Table S3,
http://links.lww.com/QAD/A603). The exception was
late presentation with AIDS (P¼ 0.03).
The mortality rate from all causes was 999 per 100 000
(95% CI 778–1284) in the lowest quintile of neighbour-
hood SEP and 959 per 100 000 (95% CI 716–1285) in the
highest quintile, with no clear trend across levels of neigh-
bourhood SEP (P¼ 0.65, Fig. 2). In the general popula-
tion, mortality clearly varied across neighbourhood SEP:
the rate per 100 000 declined from 419 (95% CI 415–423)
to 347 (95% CI 343–351) per 100 000 when moving from
the lowest to the highest quintile of neighbourhood SEP
(P< 0.001, Fig. 2). The standardized mortality ratio
(SMR) comparing mortality in the SHCS with mortality
in the general population was 3.91 (95% CI 3.45–4.43).
The majority of deaths in the SHCS (193, 78.5%) related
to causes other than AIDS. There was some evidence for a
higher proportion of deaths from AIDS in the lower than
the higher quintiles of SEP, and a trend in the same
direction for deaths of unknown causes, but differences in
the distribution of causes of death overall were not
statistically significant (P¼ 0.11, supplemental Table S4,
http://links.lww.com/QAD/A603).
Discussion
We examined whether the SEP of neighbourhoods
of residence influenced presentation and outcomes in
HIV-infected patients in Switzerland. Compared with
patients living in neighbourhoods of lower SEP, those
residing in areas of higher SEP had higher educational
attainment, were more likely to be MSM, to live in urban
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Fig. 1. Map of quintiles of Swiss neighbourhood index of socioeconomic position of 1.29 million neighbourhoods, Switzerland
2000. Quintile 1 describes neighbourhoods of lowest socio-economic position, quintile 5 neighbourhoods of highest position.
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centres and to occupy managerial positions. The
proportion of patients with a history of IDU and the
proportion exposed to HBV or HCV decreased with
increasing SEP of neighbourhoods, whereas the median
CD4þ cell count increased with higher SEP. Late
presentation and presentation with advanced HIV disease
were more common in neighbourhoods of lower SEP,
and virologic response to cART more likely in
neighbourhoods of higher SEP, but there was little
evidence of an association with mortality.
Geocoding of patients’ addresses allowed us to assign
an index of neighbourhood SEP [18] to over 90% of
eligible patients. The index was constructed using both
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Table 1. Patient characteristics at enrolment by neighbourhood socioeconomic position.
Characteristic
Neighbourhood socio-economic position (quintile)
P1 2 3 4 5
No. of participants 1011 (22.5) 864 (19.3) 885 (19.7) 897 (20.0) 832 (18.5)
No. of women 392 (38.8) 277 (32.1) 252 (28.5) 269 (30.0) 170 (20.4) <0.001
Median (IQR) age (years) 36 (30–43) 36 (30–44) 37 (32–46) 37 (30–44) 38 (32–45) <0.001
Injection drug use <0.001
Never 827 (81.8) 715 (82.8) 762 (86.1) 775 (86.4) 748 (89.9)
Former 124 (12.3) 109 (12.6) 93 (10.5) 89 (9.9) 66 (7.9)
Current 60 (5.9) 40 (4.6) 30 (3.4) 33 (3.7) 18 (2.2)
HIV transmission groups <0.001
Heterosexual contact (HET) 559 (55.3) 422 (48.8) 397 (44.9) 354 (39.5) 271 (32.6)
MSM 242 (23.9) 290 (33.6) 359 (40.6) 407 (45.4) 465 (55.9)
IDU 153 (15.1) 120 (13.9) 92 (10.4) 100 (11.2) 61 (7.3)
Other/unknown 57 (5.6) 32 (3.7) 37 (4.2) 36 (4.0) 37 (4.2)
Sexual partners <0.001
Stable partner only 496 (49.1) 395 (45.7) 370 (41.8) 395 (44.0) 364 (43.8)
Stable and occasional 102 (10.1) 109 (12.6) 137 (15.5) 124 (13.8) 148 (17.8)
Occasional partner only 170 (16.8) 177 (20.5) 187 (21.1) 199 (22.2) 191 (23.0)
No partner 212 (21.0) 159 (18.4) 171 (19.3) 159 (17.7) 111 (13.3)
Unknown 31 (3.1) 24 (2.8) 20 (2.3) 20 (2.2) 18 (2.2)
Occupationa <0.001
Self-employed 76 (7.5) 66 (7.6 ) 67 (7.6) 85 (9.5) 81 (9.7)
Higher management 14 (1.4) 21 (2.4) 27 (3.1) 34 (3.8) 43 (5.2)
Middle/lower management 63 (6.2) 56 (6.5) 67 (7.6) 83 (9.3) 84 (10.1)
Employee 475 (47.1) 369 (42.7 ) 382 (43.2) 368 (41.0) 307 (36.9)
Student 16 (1.6) 11 (1.3) 9 (1.0) 15 (1.7) 13 (1.6)
Apprentice/trainee 20 (2.0) 10 (1.2) 16 (1.8) 12 (1.3) 2 (0.2)
Househusband/wife 49 (4.9) 36 (4.2) 31 (3.5) 29 (3.2) 22 (2.6)
Other/unknown 278 (27.5) 287 (33.2) 280 (31.6) 263 (29.3) 276 (33.2)
Education <0.001
Compulsory school 380 (37.6) 287 (33.2) 238 (26.9) 225 (25.1) 128 (15.4)
Vocational training 452 (44.7) 373 (43.2) 441 (49.8) 408 (45.5) 375 (45.1)
Higher education 177 (17.5) 194 (22.5) 199 (22.5) 260 (29.0) 325 (39.1)
Other/unknown 2 (0.2) 10 (1.2) 7 (0.8) 4 (0.5) 4 (0.5)
Smoking status 0.07
Never 424 (41.9) 331 (38.3) 329 (37.2) 354 (39.5) 370 (44.5)
Former 128 (12.6) 125 (14.5) 140 (15.8) 137 (15.3) 126 (15.1)
Current 455 (45.0) 406 (47.0) 411 (46.4) 404 (45.0) 335 (40.3)
Unknown 4 (0.4) 2 (0.2) 5 (0.6) 2 (0.2) 1 (0.1)
Region of origin <0.001
Switzerland, North-West Europe 498 (49.3) 487 (56.4) 551 (62.3) 559 (62.3) 556 (66.8)
Southern Europe 99 (9.8) 92 (10.75) 65 (7.3) 68 (7.6) 57 (6.9)
Sub-Saharan Africa 257 (25.4) 164 (19.0) 149 (16.8) 141 (15.7) 98 (11.8)
Latin America 45 (4.5) 33 (3.8) 39 (4.4) 47 (5.2) 39 (4.7)
Asia, Eastern Europe 75 (7.4) 64 (7.4) 48 (5.4) 66 (7.4) 52 (6.3)
Other/unknown 37 (3.7) 24 (2.8) 33 (3.7) 16 (1.8) 30 (3.6)
Main source of income <0.001
Salaried work 462 (45.7) 461 (53.4) 515 (58.2) 532 (59.3) 554 (66.6)
Welfare benefits 410 (40.6) 288 (33.3) 273 (30.9) 247 (27.5) 181 (21.8)
Support from family or partner 124 (12.3) 103 (11.9) 90 (10.2) 112 (12.5) 88 (10.6)
Other/unknown 15 (1.5) 12 (1.4) 7 (0.8) 6 (0.7) 9 (1.1)
Level of urbanization
Urban 504 (49.9) 424 (49.1) 474 (53.6) 465 (51.8) 456 (54.8) <0.001
Peri-urban 350 (34.6) 308 (35.7) 310 (35.0) 391 (43.6) 362 (43.5)
Rural 157 (15.5) 132 (15.3) 101 (11.4) 41 (4.6) 14 (1.7)
Analysis based on a total of 4489 patients. Numbers (percentages) are shown. P values from Kruskal–Wallis tests for continuous variables and chi-
squared tests for categorical variables. Quintile 1 describes neighbourhoods of lowest SEP, quintile 5 neighbourhoods of highest SEP. IQR, inter-
quartile range.
aCurrent or last held profession.
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individual-level information on education and occupation,
and household-level information on rent and crowding.
The small size of neighbourhoods is a strength: previous
analyses of regional health disparities were generally based
on larger administrative areas with arbitrary, fixed
boundaries, for example municipalities, census units or,
in Switzerland, cantons [24]. Although the importance of
analyses based on a finer resolution has been highlighted
[5,25], such analyses are not possible in many countries.
Areas centred on the residence of individuals, with sliding
rather than fixed boundaries, define neighbourhoods that
should capture the environmental and social conditions to
which an individual is exposed to. It therefore seems
likely that the neighbourhoods and their index of SEP
reflect contextual neighbourhood effects, as well as
compositional effects that stem from the population
characteristics of residents in the neighbourhoods [26].
Indeed, associations with neighbourhood SEP persisted
when adjusting models for individual-level variables such
as education, occupation, source of income or smoking,
although they were attenuated.
Established in 1988, the SHCS is one of the longest
running HIV cohort studies worldwide [16]. About 70%
of patients living with AIDS are enrolled in the SHCS and
70% of the antiretroviral drugs sold in the country are
prescribed within the study [16,27]. We had to exclude
patients seen in private practices who were better
educated and more likely to be in salaried work than
the patients included in our study. Other limitations
include the relatively small number of patients and events,
which meant that the statistical power to detect or
exclude differences was limited for some outcomes. For
example, when comparing mortality of those living in
neighbourhoods in the highest quintile of SEP with those
in the lowest quintile, results were compatible with almost
a 40% lower and a 60% higher mortality. Finally, the
number of deaths was too small to allow detailed analyses
of cause-specific mortality. The Danish HIV Cohort
study recently reported that mortality was higher in
patients with low educational attainment compared with
patients with high attainment, particularly for smoking
and alcohol-related causes [28].
A county-level analysis in the United States of America
showed that in the cARTera, survival decreased with an
increasing proportion of people living below the poverty
level and with the level of unemployment in the counties
[29]. Another study examined racial/ethnic disparities in
mortality among people living with AIDS in San
Francisco [30]. Delayed initiation of cART or no
treatment in black people living with AIDS was strongly
associated with neighbourhood SEP. Indeed, the
disparity in mortality between black and white people
disappeared when neighbourhood SEP was included in
model [30]. Our study showed little difference in
mortality across levels of SEP of neighbourhoods
in patients enrolled in the SHCS. One explanation
might be the unrestricted access to healthcare in
Switzerland: health insurance is compulsory for all
residents, covers HIV treatment and care, and is
subsidized in those with low incomes [31]. Of note, in
British Columbia, where healthcare is also universal,
survival differences were nevertheless observed across
levels of neighbourhood SEP [32].
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Table 2. CD4R cell count, clinical stage and prevalence of exposure hepatitis B and C at enrolment and at start of combination antiretroviral
therapy by quintile of neighbourhood socio-economic position.
Characteristic
Neighbourhood socio-economic position (quintile)
P1 2 3 4 5
At enrolment (n¼2648) N¼578 N¼512 N¼519 N¼521 N¼518
Median CD4þ cell count (IQR), cells/ml 355 (193–551) 350 (201–508) 378 (216–522) 372 (235–542) 361 (215–520) 0.15
CDC clinical stage C 9.3% (54/578) 11.5% (59/512) 6.9% 8.1% (42/521) 6.2% (32/518) 0.011
(36/519)
Median HIV-RNA log10 4.6 4.6 4.6 4.6 4.6 0.46
(IQR), copies/ml (3.9–5.1) (3.9–5.1) (4.0–5.1) (3.9–5.1) (4.0–5.1)
Exposure to hepatitis B 17.6% 19.2% 15.2% 16.0% 13.4% 0.03
(92/524) (87/453) (71/467) (75/468) (63/470)
Exposure to hepatitis C 18.0% 16.3% 11.8% 12.8% 7.5% <0.001
(102/568) (82/502) (60/508) (66/514) (38/509)
At the start of cART (n¼3496) N¼799 N¼666 N¼701 N¼689 N¼641
Median CD4þ cell count (IQR), cells/ml 220 223 252 253 259 <0.001
(102–330) (128–337) (133–362) (136–360) (146–363)
CDC clinical stage C 19.5% 19.5% 15.7% 16.0% 15.1% 0.006
(156/799) (130/666) (110/701) (110/689) (97/641)
Median HIV-RNA log10 4.8 4.8 4.8 4.8 4.8 0.12
(IQR), copies/ml (4.0–5.3) (4.0–5.4) (4.1–5.3) (4.0–5.3) (4.2–5.4)
Exposure to hepatitis B 17.4% 18.8% 13.6% 15.4% 14.1% 0.044
(106/608) (94/499) (72/528) (80/520) (69/491)
Exposure to hepatitis C 12.2% 12.6% 9.0% 9.7% 5.6% <0.001
(92/757) (79/626) (60/668) (63/647) (34/611)
Analyses based on patients who were ART-naive at enrolment or start of therapy. Quintile 1 describes neighbourhoods of lowest SEP, quintile 5
neighbourhoods of highest SEP. P values from tests of trend. IQR, interquartile range.
 Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
To our knowledge, this is the first study examining the
association between neighbourhood SEP and late
presentation, as defined by a European working group
[19]. A recent analysis of 23 cohort studies by the
Collaboration of Observational HIV Epidemiological
Research Europe (COHERE) found that although late
presentation had decreased since 2000, particularly in
MSM, it remained an important problem across Europe.
Late presentation was associated with increased mortality
in some, but not all regions [33].
In conclusion, our study shows that in Switzerland,
residence in neighbourhoods of low SEP is associated
with late presentation of HIV-positive people and
presentation with advanced disease. However, the late
presentation to care did not translate into increased
mortality in subsequent years.
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Fig. 2. Mortality rates in the Swiss HIV Cohort Study com-
pared with the general population of Switzerland, 2000–
2008. Analysis based on 4489 patients from Swiss HIV Cohort
Study and 5.65 mio individuals from the general population.
SEP, socio-economic position.
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